Impact of rhinoviruses on pediatric community-acquired pneumonia

Susanna Esposito1, Cristina Daleno, Claudia Tagliabue

  • 1Department of Maternal and Pediatric Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 9, 20122, Milano, Italy.

Insights

Rhinoviruses (RVs) are a common cause of community-acquired pneumonia (CAP) in children of all ages, with RV-A being the most prevalent strain. Clinical relevance appears mild to moderate, regardless of RV type or co-infections.

Area of Science:

  • Pediatrics
  • Virology
  • Infectious Diseases

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of childhood illness.
  • Rhinoviruses (RVs) are known respiratory pathogens, but their specific role in pediatric CAP requires further elucidation.

Purpose of the Study:

  • To evaluate the prevalence and characteristics of rhinoviruses (RVs) in children diagnosed with community-acquired pneumonia (CAP).
  • To determine the association of different RV groups (A, B, C) and co-infections with CAP severity in pediatric patients.

Main Methods:

  • Respiratory secretions from 592 children with radiographically confirmed CAP were analyzed using RVP Fast assay.
  • Rhinovirus-positive samples were further characterized by real-time polymerase chain reaction and sequencing.
  • Patient data, including age and viral co-infections, were collected and analyzed.

Main Results:

  • Rhinoviruses were identified in 172 out of 592 children (29.0%) with CAP.
  • RVs were detected across all age groups: 36.3% in children <1 year, 27.3% in those aged 1-3 years, and 26.3% in children ≥4 years.
  • Rhinovirus group A was the most common type (49.1%), followed by group C (31.1%) and group B (10.1%). RVs were found as single agents in 58.3% of cases and with co-infections in 40.7%.

Conclusions:

  • Rhinoviruses are a frequent cause of community-acquired pneumonia in children across a wide age range.
  • Rhinovirus group A is the predominant strain associated with pediatric CAP.
  • The clinical presentation of RV-associated CAP appears mild to moderate, with no significant differences observed between RV groups or single versus co-infections.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: